FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Bioresearch Monitoring Violations Found

[ Price : $8.95]

FDA warns Stephen Fallon of Wilton Manors, FL, about bioresearch violations in his role as clinical investigator of a trial of an ...

Repeat Fenwal International CGMP Issues Cited

[ Price : $8.95]

FDA cautions Fenwal International about CGMP deviations at its Maricao, Puerto Rico, facility that manufactures blood pack units.

FDA Planning Pregnancy Exposure Registry Study

[ Price : $8.95]

FDA solicits public comment on a proposed study to learn from healthcare providers their understanding of barriers to higher patie...

Traveres Filspari Promotion Overstates Kidney Benefits: FDA

[ Price : $8.95]

FDA cites Travere Therapeutics over promotional materials for Filspari (sparsentan) because they contain misleading claims about t...

Intellia BLA Gets Priority Review for Hereditary Angioedema

[ Price : $8.95]

FDA accepts for priority review an Intellia Therapeutics BLA for lonvo-z, an in vivo CRISPR-based therapy for treating hereditary ...

Krazatis Accelerated Approval for Colorectal Cancer Withdrawn

[ Price : $8.95]

FDA acknowledges that Bristol Myers Squibbs accelerated approval of Krazati (adagrasib) in combination with cetuximab for adults w...

FDA Acting Center Directors Made Permanent

[ Price : $8.95]

HHS names CDER acting director Michael Davis and CBER acting director Karim Mikhail as permanent directors of their respective off...

FDA Eases Compounding for Neonatal Parenteral Nutrition Drugs

[ Price : $8.95]

FDA issues a guidance entitled Temporary Policies for Compounding Certain Starter Parenteral Nutrition Drug Products for Neonates ...

Heartvues MRI-Reviewing Software Cleared

[ Price : $8.95]

FDA grants Heartvue.ai a 510(k) clearance for its Heartvue.Proton, a machine learningpowered software for viewing, post-processing...

AstraZeneca Wins Accelerated Approval for Breast Cancer Drug

[ Price : $8.95]

FDA grants AstraZenenca an accelerated approval for Etcamah (camizestrant), an estrogen receptor antagonist, in combination with a...